Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-01-17
2006-01-17
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S422000, C424S430000, C424S433000, C424S451000, C424S464000, C424S489000
Reexamination Certificate
active
06986901
ABSTRACT:
The invention relates to compositions and methods for treating and/or preventing lower gastrointestinal (GI) disorders in mammalian patients, more particularly for alleviating and/or preventing the lower GI symptoms associated with such disorders.
REFERENCES:
patent: 3158538 (1964-11-01), Lee
patent: 3257275 (1966-06-01), Weisberg et al.
patent: 4301163 (1981-11-01), Torossian et al.
patent: 4462982 (1984-07-01), Samejima et al.
patent: 4681755 (1987-07-01), Colombo et al.
patent: 5143728 (1992-09-01), Cappel et al.
patent: 5245080 (1993-09-01), Aubard et al.
patent: 5486160 (1996-01-01), Rossi et al.
patent: 5498422 (1996-03-01), Nakamichi et al.
patent: 5516524 (1996-05-01), Kais et al.
patent: 5574054 (1996-11-01), Kitagawa et al.
patent: 5614536 (1997-03-01), Monti et al.
patent: 5656286 (1997-08-01), Miranda et al.
patent: 5658888 (1997-08-01), Koga et al.
patent: 5686494 (1997-11-01), Asano et al.
patent: 5693337 (1997-12-01), Suzuki et al.
patent: 5700410 (1997-12-01), Nakamichi et al.
patent: 5719197 (1998-02-01), Kanios et al.
patent: 5776495 (1998-07-01), Duclos et al.
patent: 5811547 (1998-09-01), Nakamichi et al.
patent: 5837285 (1998-11-01), Nakamichi et al.
patent: 5919760 (1999-07-01), Simon
patent: 5980882 (1999-11-01), Eichman
patent: 5981557 (1999-11-01), Nagasawa et al.
patent: 6024976 (2000-02-01), Miranda et al.
patent: 6027747 (2000-02-01), Terracol et al.
patent: 6090412 (2000-07-01), Hashimoto et al.
patent: 6121301 (2000-09-01), Nagasawa et al.
patent: 6127418 (2000-10-01), Bueno et al.
patent: 6156771 (2000-12-01), Rubin et al.
patent: 967977 (1975-05-01), None
patent: 2136164 (1995-03-01), None
patent: 1092314 (1993-03-01), None
patent: 1118267 (1994-05-01), None
patent: 9859499 (1998-12-01), None
patent: 0 465 234 (1992-01-01), None
patent: 857482 (1997-02-01), None
patent: 2244469 (1973-08-01), None
patent: 4506 (1993-08-01), None
patent: 2771009 (1997-11-01), None
patent: 56128719 (1980-03-01), None
patent: 3066627 (1989-08-01), None
patent: 9052829 (1995-06-01), None
patent: WO 9501803 (1995-01-01), None
patent: WO 9725979 (1996-01-01), None
patent: WO 0076500 (2000-12-01), None
patent: WO 0121601 (2001-03-01), None
patent: 6101840 (1993-08-01), None
JW Read, JL Abitbol, KD Bardhan, PJ Whorwell, B Fraitag—“Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia [see comments],” Gut Nov., 1997 41(5):664-8.
M Delvaux, D Louvel, E Lagier, B Scherrer, JL Abitbol, J Frexinos—“The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.” Gastroenetrology, Jan.; 1999 116(1):38-45.
HD Allescher HD, S Ahmad, M Classen, EE Daniel—“Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.” J Pharmacol Exp Ther 257:836-42, May 1991.
T. Kamiya et al., “Effects of trimebutine maleate on gastric motility in patients with gastric ulcer”, Journal of Gastroenterology, vol. 33, No. 6, Dec. 1998, pp. 823-827.
J. Kountouras MD, et al., “Efficacy of Trimebutine Therapy in Patients with Gastroesophageal Reflux Disease and Irritable Bowel Syndrome”, Hepato-Gastroenterology Jan. 2002; vol. 49, 193-197.
Ciociola Arthur A.
Meisel Gerard M.
Page Thurman K.
Tran S.
Vag Linda A.
Warner-Lambert Company LLC
LandOfFree
Gastrointestinal compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gastrointestinal compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastrointestinal compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3550458